Cypress Point Wealth Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,272
Closed -$217K 29
2022
Q1
$217K Hold
3,272
0.22% 32
2021
Q4
$327K Hold
3,272
0.3% 26
2021
Q3
$409K Hold
3,272
0.29% 23
2021
Q2
$406K Hold
3,272
0.29% 22
2021
Q1
$499K Hold
3,272
0.52% 15
2020
Q4
$422K Buy
+3,272
New +$376K 0.64% 55

Other funds holding GH

Cypress Point Wealth Management's GH Position: Q2 2022 in Review

Cypress Point Wealth Management sold out of Guardant Health (GH) in Q2 2022, closing a stake of 3,272 shares — an estimated $217K sold.

Cypress Point Wealth Management first reported a position in GH in Q4 2020 and held it in 6 quarters. The position peaked at $499K in Q1 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Cypress Point Wealth Management reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • Cypress Point Wealth Management sold 3,272 Guardant Health shares in Q2 2022, an estimated $217K.
  • Cypress Point Wealth Management first reported a position in Guardant Health in Q4 2020 and held it in 6 quarters.
  • Cypress Point Wealth Management's Guardant Health position peaked at $499K in Q1 2021.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Cypress Point Wealth Management's 13F filing for Q2 2022, filed 8 Aug 2022.